Royce & Associates LP Purchases 18,091 Shares of Azenta, Inc. (NASDAQ:AZTA)

Royce & Associates LP grew its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 2.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 758,068 shares of the company’s stock after purchasing an additional 18,091 shares during the period. Royce & Associates LP owned approximately 1.66% of Azenta worth $37,903,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in AZTA. State of New Jersey Common Pension Fund D lifted its holdings in shares of Azenta by 9.5% during the third quarter. State of New Jersey Common Pension Fund D now owns 40,008 shares of the company’s stock valued at $1,938,000 after purchasing an additional 3,469 shares during the last quarter. Aigen Investment Management LP purchased a new position in shares of Azenta during the third quarter valued at approximately $214,000. Victory Capital Management Inc. lifted its holdings in shares of Azenta by 4.0% during the third quarter. Victory Capital Management Inc. now owns 27,281 shares of the company’s stock valued at $1,321,000 after purchasing an additional 1,061 shares during the last quarter. Quest Partners LLC lifted its holdings in shares of Azenta by 31.5% during the third quarter. Quest Partners LLC now owns 7,941 shares of the company’s stock valued at $385,000 after purchasing an additional 1,902 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Azenta during the third quarter valued at approximately $1,979,000. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AZTA has been the subject of several recent research reports. Evercore ISI lifted their target price on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a report on Thursday, February 6th. Needham & Company LLC boosted their price objective on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday, February 6th. Stephens restated an “overweight” rating and issued a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Finally, TD Cowen upgraded shares of Azenta to a “hold” rating in a report on Thursday, February 27th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $58.75.

Azenta Stock Up 0.7 %

Shares of NASDAQ AZTA opened at $36.80 on Friday. The firm has a market cap of $1.68 billion, a P/E ratio of -12.35 and a beta of 1.52. The company has a 50 day moving average of $48.16 and a 200 day moving average of $47.05. Azenta, Inc. has a twelve month low of $35.90 and a twelve month high of $63.58.

Azenta (NASDAQ:AZTA) last announced its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, equities analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.